Francesco Autore相关文献与解析，生知库 | 链接生命科学的每一步

Fresa, Alberto; Innocenti, Idanna; Tomasso, Annamaria; Stirparo, Luca; Mosca, Antonio; Iadevaia, Francesco; Autore, Francesco; Ghia, Paolo; Laurenti, Luca

细胞生物学

白血病

发表日期：2024

文献求助收藏

Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature

一例复发/难治性慢性淋巴细胞白血病合并纯红细胞再生障碍性贫血患者成功接受阿卡替尼治疗：病例报告及文献复习

期刊:Therapeutic Advances in Hematology

影响因子:3.1

doi:10.1177/20406207241282570

Fresa, Alberto; Innocenti, Idanna; Tomasso, Annamaria; Stirparo, Luca; Mosca, Antonio; Iadevaia, Francesco; Autore, Francesco; Laurenti, Luca

Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response

miR-181b 在 CLL B 细胞中的表达增强可改善抗肿瘤细胞毒性 T 细胞反应

期刊:Cancers

影响因子:

doi:10.3390/cancers13020257

Mirco Di Marco, Serena Veschi, Paola Lanuti, Alice Ramassone, Stefania Pacillo, Sara Pagotto, Felice Pepe, Jonahunnatha Nesson George-William, Claudia Curcio, Marco Marchisio, Sebastiano Miscia, Idanna Innocenti, Francesco Autore, Barbara Vannata, Patrizia Di Gregorio, Mario Di Gioacchino, Silvia Va

HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia

HNRNPL 抑制 miR-155 靶向 BUB1，从而稳定慢性淋巴细胞白血病中转化细胞的异常核型

期刊:Cancers

影响因子:

doi:10.3390/cancers11040575

Sara Pagotto, Angelo Veronese, Alessandra Soranno, Veronica Balatti, Alice Ramassone, Paolo E Guanciali-Franchi, Giandomenico Palka, Idanna Innocenti, Francesco Autore, Laura Z Rassenti, Thomas J Kipps, Renato Mariani-Costantini, Luca Laurenti, Carlo M Croce, Rosa Visone3

Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL

在 Eμ-TCL1 转基因小鼠慢性淋巴细胞白血病模型中，两种类型的 BCR 相互作用在白血病发展过程中受到正向选择

期刊:Blood

影响因子:21

doi:10.1182/blood-2014-07-587790

Stefano Iacovelli, Eva Hug, Sara Bennardo, Marcus Duehren-von Minden, Stefania Gobessi, Andrea Rinaldi, Mirza Suljagic, Daniel Bilbao, Giulia Bolasco, Julia Eckl-Dorna, Verena Niederberger, Francesco Autore, Simona Sica, Luca Laurenti, Hongsheng Wang, Richard J Cornall, Stephen H Clarke, Carlo M Cro

Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed

2024年慢性淋巴细胞白血病治疗顺序：现状与未来展望

Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature

一例复发/难治性慢性淋巴细胞白血病合并纯红细胞再生障碍性贫血患者成功接受阿卡替尼治疗：病例报告及文献复习

Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response

miR-181b 在 CLL B 细胞中的表达增强可改善抗肿瘤细胞毒性 T 细胞反应

HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia

HNRNPL 抑制 miR-155 靶向 BUB1，从而稳定慢性淋巴细胞白血病中转化细胞的异常核型

Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL

在 Eμ-TCL1 转基因小鼠慢性淋巴细胞白血病模型中，两种类型的 BCR 相互作用在白血病发展过程中受到正向选择